日本药局福利管理市场报告（按服务、商业模式、最终用途和地区）2025-2033

2024年，日本药品福利管理市场规模达356.59亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到557.38亿美元，2025-2033年期间的复合年增长率（CAGR）为5.1%。市场成长的驱动力源自于对处方药成本效益管理日益增长的需求，以及机器学习（ML）和人工智慧（AI）技术的融合。

药房福利管理 (PBM) 是指代表健康保险计划、雇主和其他组织管理处方药项目的第三方实体。它在管理和优化提供给计划成员或员工的药品福利方面发挥着至关重要的作用。药房福利管理充当药房、药品製造商和医疗保健支付方之间的中介，促进处方药的有效和高效交付。它执行各种功能，包括与製药公司协商药品价格、开发和维护处方集、处理处方索赔以及管理药房网路。药局福利管理旨在控制处方药成本、促进仿製药的使用、确保用药安全并改善整体健康状况。

日本药局福利管理市场趋势：

在日本市场，其成长的驱动力在于对处方药成本有效管理的迫切需求。此外，药品价格上涨也加剧了医疗保险提供者对药品福利管理 (PBM) 服务的需求，为市场扩张创造了诱人的机会。此外，由于类似药物的活性药物成分 (API) 略有不同，消费者对价格的敏感度也随之提高，从而导致对 PBM 服务的需求增加。此外，机器学习 (ML) 和人工智慧 (AI) 技术的融合在提升营运效率方面发挥了关键作用。这些技术简化了供应链流程，加快了订单交付速度，并在有限的时间内满足了多家保险和零售药局连锁店的需求。此外，由于药品福利管理系统能够提供更强大的专业知识并与领先公司建立联繫，因此其用户群正显着转向药品福利管理系统。此外，医疗资料的持续改进和可用性的提升正在推动区域市场发生重大变革。除此之外，PBM 正在利用资料分析、人工智慧和机器学习的潜力来提供更个人化、数据驱动的药房福利解决方案，预计这将推动未来几年的市场成长。

日本药局福利管理市场区隔：

服务洞察：

• 专业药局服务
• 药品处方集管理
• 零售药局服务
• 福利计划设计与咨询
• 疾病管理服务
• 其他的

商业模式洞察：

• 健康保险管理
• 独立PBM
• 零售药局

最终用途洞察：

• 联邦
• 商业的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

• 日本药品福利管理市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本药品福利管理市场有何影响？
• 日本药品福利管理市场如何依服务划分？
• 日本药品福利管理市场根据商业模式如何划分？
• 日本药品福利管理市场依照最终用途的划分是怎样的？
• 日本药品福利管理市场的价值链分为哪些阶段？
• 日本药品福利管理的主要驱动因素和挑战是什么？
• 日本药品福利管理市场的结构是怎么样的？主要参与者是谁？
• 日本药品福利管理市场的竞争程度如何？

本报告回答的关键问题：

• 日本药品福利管理市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本药品福利管理市场有何影响？
• 日本药品福利管理市场如何依服务划分？
• 日本药品福利管理市场根据商业模式如何划分？
• 日本药品福利管理市场依照最终用途的划分是怎样的？
• 日本药品福利管理市场的价值链分为哪些阶段？
• 日本药品福利管理的主要驱动因素和挑战是什么？
• 日本药品福利管理市场的结构是怎么样的？主要参与者是谁？
• 日本药品福利管理市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

• 研究目标
• 利害关係人
• 资料来源
  • 主要来源
  • 次要来源
• 市场评估
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第三章：执行摘要

第四章：日本药品福利管理市场 - 简介

• 概述
• 市场动态
• 产业趋势
• 竞争情报

第五章：日本药品福利管理市场格局

• 历史与当前市场趋势（2019-2024）
• 市场预测（2025-2033）

第六章：日本药品福利管理市场-细分：依服务

• 专业药局服务
  • 概述
• 药品处方集管理
  • 概述
• 零售药局服务
  • 概述
• 福利计划设计与咨询
  • 概述
• 疾病管理服务
  • 概述
• 其他的

第七章：日本药品福利管理市场-细分：依商业模式

• 健康保险管理
  • 概述
• 独立PBM
  • 概述
• 零售药局
  • 概述

第 8 章：日本药品福利管理市场 - 分拆：最终用途别

• 联邦
  • 概述
• 商业的
  • 概述

第九章：日本药品福利管理市场－竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳获胜策略
• 竞争仪錶板
• 公司评估象限

第十章：关键参与者简介

• Company A
• Business Overview
• Services Offered
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Services Offered
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Services Offered
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Services Offered
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Services Offered
• Business Strategies
• SWOT Analysis
• Major News and Events

第 11 章：日本药品福利管理市场 - 产业分析

• 驱动因素、限制因素和机会
  • 概述
  • 驱动程式
  • 限制
  • 机会
• 波特五力分析
  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁
• 价值链分析

第 12 章：附录

Japan pharmacy benefit management market size reached USD 35,659 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 55,738 Million by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is being driven by the increasing demand for cost-effective management of prescription medications and the incorporation of machine learning (ML) and artificial intelligence (AI) technologies.

Pharmacy benefit management (PBM) refers to the third-party entities that administer prescription drug programs on behalf of health insurance plans, employers, and other organizations. It plays a crucial role in managing and optimizing the pharmaceutical benefits provided to plan members or employees. Pharmacy benefit management acts as intermediaries between pharmacies, drug manufacturers, and healthcare payers, facilitating the effective and efficient delivery of prescription medications. It performs various functions, including negotiating drug prices with pharmaceutical companies, developing, and maintaining formularies, processing prescription claims, and managing pharmacy networks. Pharmacy benefit management aims to control prescription drug costs, promote generic drug utilization, ensure medication safety, and improve overall health outcomes.

Japan Pharmacy Benefit Management Market Trends:

In the Japan market, the driving force behind its growth lies in the imperative need for effective management of prescription drug costs. Additionally, the increasing pricing of medications has intensified the demand for pharmacy benefit management (PBM) services among health insurance providers, creating attractive opportunities for market expansion. Furthermore, the presence of similar drugs with slight variations in their active pharmaceutical ingredients (API) has heightened price sensitivity among consumers, resulting in a heightened demand for PBM services. Furthermore, the incorporation of machine learning (ML) and artificial intelligence (AI) technologies has played a pivotal role in enhancing operational efficiency. These technologies have streamlined supply chain processes, facilitated swifter order delivery, and catered to multiple insurance and retail pharmacy chains within limited timeframes. Additionally, there is a noticeable shift towards pharmacy benefit management systems due to their capacity to provide enhanced expertise and establish connections with leading companies. Furthermore, ongoing enhancements and the increasing availability of healthcare data are instigating significant transformations within the regional market. Apart from this, PBMs are harnessing the potential of data analytics, artificial intelligence, and machine learning to offer more personalized, data-driven pharmacy benefit solutions, which is expected to fuel the market growth in the coming years.

Japan Pharmacy Benefit Management Market Segmentation:

Service Insights:

• Specialty Pharmacy Services
• Drug Formulary Management
• Retail Pharmacy Services
• Benefit Plan Design and Consultation
• Disease Management Services
• Others

Business Model Insights:

• Health Insurance Management
• Standalone PBMs
• Retail Pharmacy

End Use Insights:

• Federal
• Commercial

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan pharmacy benefit management market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan pharmacy benefit management market?
• What is the breakup of the Japan pharmacy benefit management market on the basis of service?
• What is the breakup of the Japan pharmacy benefit management market on the basis of business model?
• What is the breakup of the Japan pharmacy benefit management market on the basis of end use?
• What are the various stages in the value chain of the Japan pharmacy benefit management market?
• What are the key driving factors and challenges in the Japan pharmacy benefit management?
• What is the structure of the Japan pharmacy benefit management market and who are the key players?
• What is the degree of competition in the Japan pharmacy benefit management market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmacy Benefit Management Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Pharmacy Benefit Management Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Pharmacy Benefit Management Market - Breakup by Service

• 6.1 Specialty Pharmacy Services
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Drug Formulary Management
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Retail Pharmacy Services
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Benefit Plan Design and Consultation
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Disease Management Services
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)
• 6.6 Others
  • 6.6.1 Historical and Current Market Trends (2019-2024)
  • 6.6.2 Market Forecast (2025-2033)

7 Japan Pharmacy Benefit Management Market - Breakup by Business Model

• 7.1 Health Insurance Management
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Standalone PBMs
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Retail Pharmacy
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)

8 Japan Pharmacy Benefit Management Market - Breakup by End Use

• 8.1 Federal
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Commercial
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)

9 Japan Pharmacy Benefit Management Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Services Offered
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Services Offered
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Services Offered
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Services Offered
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Services Offered
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Pharmacy Benefit Management Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix